Free Trial

BioLife Solutions (BLFS) Competitors

BioLife Solutions logo
$25.97 +0.17 (+0.66%)
As of 12:04 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

BLFS vs. SLNO, TMDX, NVST, LIVN, WRBY, INSP, LQDA, PRCT, LMAT, and AORT

Should you be buying BioLife Solutions stock or one of its competitors? The main competitors of BioLife Solutions include Soleno Therapeutics (SLNO), TransMedics Group (TMDX), Envista (NVST), LivaNova (LIVN), Warby Parker (WRBY), Inspire Medical Systems (INSP), Liquidia Technologies (LQDA), PROCEPT BioRobotics (PRCT), LeMaitre Vascular (LMAT), and Artivion (AORT). These companies are all part of the "medical equipment" industry.

BioLife Solutions vs. Its Competitors

Soleno Therapeutics (NASDAQ:SLNO) and BioLife Solutions (NASDAQ:BLFS) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, media sentiment, profitability, dividends, analyst recommendations, risk, valuation and institutional ownership.

Soleno Therapeutics presently has a consensus price target of $115.09, indicating a potential upside of 132.95%. BioLife Solutions has a consensus price target of $31.29, indicating a potential upside of 20.47%. Given Soleno Therapeutics' higher possible upside, research analysts clearly believe Soleno Therapeutics is more favorable than BioLife Solutions.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Soleno Therapeutics
0 Sell rating(s)
0 Hold rating(s)
11 Buy rating(s)
1 Strong Buy rating(s)
3.08
BioLife Solutions
0 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
3.13

In the previous week, Soleno Therapeutics had 25 more articles in the media than BioLife Solutions. MarketBeat recorded 36 mentions for Soleno Therapeutics and 11 mentions for BioLife Solutions. BioLife Solutions' average media sentiment score of 0.68 beat Soleno Therapeutics' score of 0.57 indicating that BioLife Solutions is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Soleno Therapeutics
7 Very Positive mention(s)
1 Positive mention(s)
13 Neutral mention(s)
2 Negative mention(s)
2 Very Negative mention(s)
Positive
BioLife Solutions
4 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Soleno Therapeutics has a beta of -2.71, indicating that its stock price is 371% less volatile than the S&P 500. Comparatively, BioLife Solutions has a beta of 1.78, indicating that its stock price is 78% more volatile than the S&P 500.

BioLife Solutions has higher revenue and earnings than Soleno Therapeutics. BioLife Solutions is trading at a lower price-to-earnings ratio than Soleno Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Soleno TherapeuticsN/AN/A-$175.85M-$4.14-11.93
BioLife Solutions$82.25M15.12-$20.18M-$0.12-216.41

Soleno Therapeutics has a net margin of 0.00% compared to BioLife Solutions' net margin of -5.39%. BioLife Solutions' return on equity of 0.16% beat Soleno Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Soleno TherapeuticsN/A -73.74% -56.67%
BioLife Solutions -5.39%0.16%0.14%

97.4% of Soleno Therapeutics shares are held by institutional investors. Comparatively, 93.2% of BioLife Solutions shares are held by institutional investors. 6.4% of Soleno Therapeutics shares are held by insiders. Comparatively, 2.2% of BioLife Solutions shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

BioLife Solutions beats Soleno Therapeutics on 8 of the 15 factors compared between the two stocks.

Get BioLife Solutions News Delivered to You Automatically

Sign up to receive the latest news and ratings for BLFS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BLFS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BLFS vs. The Competition

MetricBioLife SolutionsMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$1.24B$10.49B$5.72B$10.26B
Dividend YieldN/A1.86%5.72%4.60%
P/E Ratio-216.4820.6475.1026.36
Price / Sales15.1229.80498.56167.32
Price / Cash208.2225.0025.8129.90
Price / Book3.453.4513.236.29
Net Income-$20.18M$210.63M$3.28B$270.30M
7 Day Performance-1.63%-1.15%0.32%1.95%
1 Month Performance6.69%1.90%4.73%6.14%
1 Year Performance2.00%-11.06%73.16%27.92%

BioLife Solutions Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BLFS
BioLife Solutions
2.6427 of 5 stars
$25.97
+0.7%
$31.29
+20.5%
+2.7%$1.24B$82.25M-216.48440News Coverage
SLNO
Soleno Therapeutics
4.4332 of 5 stars
$72.30
+3.6%
$115.09
+59.2%
-3.2%$3.71BN/A-17.4630Positive News
Short Interest ↑
TMDX
TransMedics Group
2.3926 of 5 stars
$105.58
+1.5%
$122.11
+15.7%
-24.5%$3.55B$441.54M54.70210Analyst Forecast
NVST
Envista
3.8252 of 5 stars
$21.14
-0.8%
$20.92
-1.0%
+8.8%$3.54B$2.51B66.0512,300Positive News
LIVN
LivaNova
3.0292 of 5 stars
$58.32
+0.6%
$59.71
+2.4%
+14.2%$3.17B$1.25B-14.992,900Positive News
WRBY
Warby Parker
1.5182 of 5 stars
$26.74
+2.8%
$24.06
-10.0%
+80.0%$2.74B$771.32M-382.003,780Positive News
Analyst Upgrade
Insider Trade
INSP
Inspire Medical Systems
4.9032 of 5 stars
$83.51
-3.4%
$164.50
+97.0%
-60.3%$2.56B$802.80M48.271,246Positive News
LQDA
Liquidia Technologies
3.6574 of 5 stars
$27.98
-3.0%
$32.11
+14.8%
+173.3%$2.48B$14M-16.4650
PRCT
PROCEPT BioRobotics
3.1603 of 5 stars
$38.92
-4.3%
$73.22
+88.1%
-53.2%$2.26B$224.50M-25.11430Positive News
Analyst Forecast
LMAT
LeMaitre Vascular
3.1789 of 5 stars
$97.07
-0.4%
$97.60
+0.5%
+3.0%$2.21B$219.86M47.12490Positive News
AORT
Artivion
2.881 of 5 stars
$43.34
-0.3%
$40.63
-6.2%
+57.4%$2.05B$388.54M-103.191,600Positive News

Related Companies and Tools


This page (NASDAQ:BLFS) was last updated on 9/16/2025 by MarketBeat.com Staff
From Our Partners